- Home
- NVX vs SGHT Comparison
NVX vs SGHT Comparison
Compare NVX & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- SGHT
- Stock Information
- Founded
- NVX 2012
- SGHT 2011
- Country
- NVX Australia
- SGHT United States
- Employees
- NVX N/A
- SGHT N/A
- Industry
- NVX Industrial Machinery/Components
- SGHT Medical Specialities
- Sector
- NVX Miscellaneous
- SGHT Health Care
- Exchange
- NVX Nasdaq
- SGHT Nasdaq
- Market Cap
- NVX 176.8M
- SGHT 179.7M
- IPO Year
- NVX N/A
- SGHT 2021
- Fundamental
- Price
- NVX $1.36
- SGHT $4.23
- Analyst Decision
- NVX
- SGHT Buy
- Analyst Count
- NVX 0
- SGHT 8
- Target Price
- NVX N/A
- SGHT $4.16
- AVG Volume (30 Days)
- NVX 376.2K
- SGHT 116.6K
- Earning Date
- NVX 01-01-0001
- SGHT 08-07-2025
- Dividend Yield
- NVX N/A
- SGHT N/A
- EPS Growth
- NVX N/A
- SGHT N/A
- EPS
- NVX N/A
- SGHT N/A
- Revenue
- NVX $5,854,424.00
- SGHT $76,303,000.00
- Revenue This Year
- NVX $135.22
- SGHT N/A
- Revenue Next Year
- NVX $1,647.66
- SGHT $11.22
- P/E Ratio
- NVX N/A
- SGHT N/A
- Revenue Growth
- NVX N/A
- SGHT N/A
- 52 Week Low
- NVX $0.81
- SGHT $2.03
- 52 Week High
- NVX $2.73
- SGHT $7.05
- Technical
- Relative Strength Index (RSI)
- NVX 54.32
- SGHT 63.28
- Support Level
- NVX $1.18
- SGHT $3.11
- Resistance Level
- NVX $1.45
- SGHT $4.28
- Average True Range (ATR)
- NVX 0.09
- SGHT 0.23
- MACD
- NVX -0.00
- SGHT 0.11
- Stochastic Oscillator
- NVX 53.75
- SGHT 97.44
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.